Rafferty Asset Management LLC bought a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 55,907 shares of the company's stock, valued at approximately $998,000. Rafferty Asset Management LLC owned 0.17% of Grail at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the business. State of Tennessee Department of Treasury acquired a new stake in Grail in the 4th quarter valued at approximately $28,000. Lindbrook Capital LLC acquired a new stake in Grail in the 4th quarter valued at approximately $28,000. Sterling Capital Management LLC acquired a new position in shares of Grail during the 4th quarter valued at $29,000. Wellington Shields Capital Management LLC acquired a new position in shares of Grail during the 4th quarter valued at $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Grail during the 4th quarter valued at $41,000.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on GRAL. Canaccord Genuity Group lifted their price target on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Morgan Stanley lifted their price target on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.
View Our Latest Analysis on GRAL
Grail Stock Down 4.7%
GRAL opened at $37.46 on Thursday. The firm has a market cap of $1.35 billion and a PE ratio of -0.61. The business has a fifty day simple moving average of $30.56 and a 200-day simple moving average of $27.08. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.
Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, topping the consensus estimate of ($4.03) by $0.93. The company had revenue of $31.84 million for the quarter, compared to the consensus estimate of $35.80 million. On average, equities research analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.
Insider Transactions at Grail
In other news, CEO Robert P. Ragusa sold 94,035 shares of the firm's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer now directly owns 734,627 shares of the company's stock, valued at $24,925,894.11. This trade represents a 11.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Aaron Freidin sold 1,816 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This represents a 0.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 194,948 shares of company stock valued at $6,583,130 in the last three months. 1.85% of the stock is currently owned by corporate insiders.
Grail Profile
(
Free Report)
GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.
Read More
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.